Oxford Biomedica PLC Holding(s) in Company (6459L)
October 04 2016 - 6:57AM
UK Regulatory
TIDMOXB TIDMAV.
RNS Number : 6459L
Oxford Biomedica PLC
04 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Oxford Biomedica plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ----------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------- ------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------- ------------------------------------------
Other (please
specify):
----------------------------------------------------------- -------- ------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 15,181,044*
Chase (GA Group) Nominees
Limited 184,629,404*
State Street Nominees Limited
37,978,277*
*denotes direct interest
Chase (GA Group) Nominees
Limited 19,344,658
Chase Nominees Limited 7,566,886
Vidacos Nominees Limited 11,939,558
------------------------------------------------------------- --------------------------------------------------
5. Date of the transaction 30 September 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------------------
6. Date on which issuer 3 October 2016
notified:
------------------------------------------------------------- --------------------------------------------------
7. Threshold(s) that is/are 8% to 9% Change at Direct
crossed or Interest Level
reached: (vi, vii) (Box 8A&B)
------------------------------------------------------------- --------------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after
of to the triggering the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- ----------------------------- --------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
--------------- ------------- -------------- ------------ ---------------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ------------- -------------- ------------ -------------- ------------ ------- ---------
Ordinary
Shares
GB00066458157 283,375,219* 283,375,219* 276,639,827 237,788,725 38,851,102 8.79% 1.44%
------------- -------------- ------------ -------------- ------------ ------- ---------
* Includes Right to Recall Loaned Shares (5,940,559)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- ------------- -------------- ------------------------------------------ ------------------
RIGHT TO 6,335,351*
RECALL
LOANED SHARES N/A N/A *DIRECT INTEREST 0.24%
--------------- ------------- -------------- ------------------------------------------ ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
282,975,178 10.47%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- -------------------------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------------------------- -------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------------------------- -------------------------------
13. Additional information: Figures are based the total
number of voting rights of
2,703,806,022 as per the
Company's Total Voting Rights
Announcement of 1 September
2016.
--------------------------------------------- -------------------------------
14. Contact name: Tim Watts
--------------------------------------------- -------------------------------
15. Contact telephone number: 01865 783000
--------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSVRRNSARRAA
(END) Dow Jones Newswires
October 04, 2016 06:57 ET (10:57 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024
